Filters
Hikma to host meet the management and site visit in Columbus, Ohio
Press Release, Corporate 17 March 2025
New
Hikma receives FDA approval and launches Mercaptopurine Oral Suspension in the US
Press Release, Product 27 February 2025
New
Strong 2024 performance and a positive outlook for 2025
Press Release, Financial Results 26 February 2025
Hikma and M42 sign strategic MOU to advance healthcare innovation in the UAE
Press Release, Business Development 30 January 2025
Hikma announces exclusive commercial partnership with Emergent BioSolutions for KLOXXADO® (naloxone HCl) nasal spray 8 m...
Press Release, Product 14 January 2025
Hikma launches Meropenem for Injection, USP in the US
Press Release, Product 14 January 2025
Hikma to present at 43rd Annual J.P. Morgan Healthcare Conference
Press Release, Corporate 13 January 2025
Hikma launches ePHEDrine Sulfate Injection, USP in the US
Press Release, Product 30 December 2024
New
Hikma receives FDA approval and launches the generic version of Victoza®, Liraglutide, in the US
Press Release, Product 26 December 2024
Hikma launches Indomethacin Suppositories in the US
Press Release, Product 20 December 2024
New
Hikma acquires the rights to a portfolio of Takeda brands for the MENA region
Press Release, Product 19 December 2024
New
Hikma and Richter announce FDA submission acceptance for Denosumab biosimilar products
Press Release, Product 12 December 2024
New
Hikma launches Furosemide Injection, USP, in the US
Press Release, Product 09 December 2024
Sell-side analysts and investors visit Hikma Casablanca site
Press Release, Corporate 14 November 2024
You have viewed 15 of 462 results